Dr. Charles Anim Berko, MD

Dr. Berko practices at Mdlive Medical Group PA in Holyoke, Massachusetts.

Dr. Berko's NPI, 1114363819, was assigned on May 21, 2013. Dr. Berko holds Pennsylvania license MD462195.

Dr. Berko's primary practice is Mdlive Medical Group PA, at 50 Holy Family Rd, Holyoke, MA 01040 in Hampden County. The practice phone is (800) 400-6354.

Dr. Berko's primary practice is Mdlive Medical Group PA in Holyoke, Massachusetts. Dr. Berko is also affiliated with University of Maryland Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Berko to 6 more hospitals, 13 medical groups, 1 group practice or clinic, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berko practices, 10 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Berko's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Berko's licenses on file in 2 states: Pennsylvania and Maryland.

CMS data shows 303 Medicare services from Dr. Berko across 3 procedure codes in 2024, for 312 Medicare patients. Medicare paid $37,465 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 312 Medicare patients who saw Dr. Berko in 2024. The largest group is 75 to 84, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berko's median patient age at 71, with 45% women.

In 2024, Dr. Berko wrote 48 Medicare Part D claims for 36 patients. 90% of them were for generic drugs. They cover 8 drugs, with $650 in total drug cost. In 2022, CMS named 168 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Berko for performance year 2024, reported as part of a group. Dr. Berko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Berko in 2014. 2014 was the busiest year, with 2. Dr. Berko's most frequent co-authors are Jonathan D'Cunha, MD, PhD, Uqba Khan, MD and Sapna P. Kuehl, MD.

CMS Open Payments shows 4 general payments to Dr. Berko from 3 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $28.